Sensus Healthcare Inc (SRTS) - Net Assets
Based on the latest financial reports, Sensus Healthcare Inc (SRTS) has net assets worth $48.10 Million USD as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($53.04 Million) and total liabilities ($4.94 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check SRTS tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $48.10 Million |
| % of Total Assets | 90.68% |
| Annual Growth Rate | 24.98% |
| 5-Year Change | 84.89% |
| 10-Year Change | 214.9% |
| Growth Volatility | 58.64 |
Sensus Healthcare Inc - Net Assets Trend (2014–2025)
This chart illustrates how Sensus Healthcare Inc's net assets have evolved over time, based on quarterly financial data. See how many days can Sensus Healthcare Inc fund operations to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Sensus Healthcare Inc (2014–2025)
The table below shows the annual net assets of Sensus Healthcare Inc from 2014 to 2025. For live valuation and market cap data, see SRTS market cap.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $48.10 Million | -13.84% |
| 2024-12-31 | $55.83 Million | +14.30% |
| 2023-12-31 | $48.84 Million | +1.61% |
| 2022-12-31 | $48.07 Million | +84.77% |
| 2021-12-31 | $26.02 Million | +21.02% |
| 2020-12-31 | $21.50 Million | -23.23% |
| 2019-12-31 | $28.00 Million | +5.83% |
| 2018-12-31 | $26.46 Million | +126.54% |
| 2017-12-31 | $11.68 Million | -23.53% |
| 2016-12-31 | $15.27 Million | +157.94% |
| 2015-12-31 | $5.92 Million | +43.10% |
| 2014-12-31 | $4.14 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Sensus Healthcare Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 1292354200.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $5.71 Million | 11.88% |
| Common Stock | $169.00K | 0.35% |
| Other Components | $42.21 Million | 87.77% |
| Total Equity | $48.10 Million | 100.00% |
Sensus Healthcare Inc Competitors by Market Cap
The table below lists competitors of Sensus Healthcare Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
CORESTATE Capital Holding S.A
XETRA:CCAP
|
$44.86 Million |
|
Arianne Phosphate Inc
V:DAN
|
$44.88 Million |
|
Lichen China Limited Class A Ordinary Shares
NASDAQ:LICN
|
$44.90 Million |
|
Ram-On Investments and Holdings Ltd
TA:RMN
|
$44.91 Million |
|
PESTECH International Bhd
KLSE:5219
|
$44.81 Million |
|
KMH Hitech Co. Ltd
KQ:052900
|
$44.79 Million |
|
Eastwood Bio-Medical Canada Inc
V:EBM
|
$44.78 Million |
|
Atec Co. Ltd
KQ:045660
|
$44.77 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Sensus Healthcare Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 55,827,000 to 48,098,000, a change of -7,729,000 (-13.8%).
- Net loss of 7,719,000 reduced equity.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-7.72 Million | -16.05% |
| Other Changes | $-10.00K | -0.02% |
| Total Change | $- | -13.84% |
Book Value vs Market Value Analysis
This analysis compares Sensus Healthcare Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.93x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 6.52x to 0.93x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2014-12-31 | $0.42 | $2.73 | x |
| 2015-12-31 | $0.55 | $2.73 | x |
| 2016-12-31 | $1.27 | $2.73 | x |
| 2017-12-31 | $0.88 | $2.73 | x |
| 2018-12-31 | $1.87 | $2.73 | x |
| 2019-12-31 | $1.72 | $2.73 | x |
| 2020-12-31 | $1.31 | $2.73 | x |
| 2021-12-31 | $1.58 | $2.73 | x |
| 2022-12-31 | $2.89 | $2.73 | x |
| 2023-12-31 | $3.00 | $2.73 | x |
| 2024-12-31 | $3.41 | $2.73 | x |
| 2025-12-31 | $2.95 | $2.73 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Sensus Healthcare Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -16.05%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -28.09%
- • Asset Turnover: 0.52x
- • Equity Multiplier: 1.10x
- Recent ROE (-16.05%) is below the historical average (-9.15%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | -89.40% | -63.67% | 0.84x | 1.68x | $-4.11 Million |
| 2015 | -4.01% | -2.31% | 1.07x | 1.63x | $-829.43K |
| 2016 | -2.27% | -2.34% | 0.78x | 1.24x | $-1.87 Million |
| 2017 | -31.77% | -18.02% | 1.09x | 1.61x | $-4.88 Million |
| 2018 | -7.64% | -7.65% | 0.79x | 1.26x | $-4.67 Million |
| 2019 | -6.07% | -6.24% | 0.74x | 1.32x | $-4.50 Million |
| 2020 | -31.80% | -71.38% | 0.34x | 1.30x | $-8.99 Million |
| 2021 | 15.83% | 15.23% | 0.84x | 1.24x | $1.52 Million |
| 2022 | 50.44% | 54.44% | 0.78x | 1.18x | $19.44 Million |
| 2023 | 0.99% | 1.99% | 0.45x | 1.10x | $-4.40 Million |
| 2024 | 11.91% | 15.90% | 0.67x | 1.11x | $1.06 Million |
| 2025 | -16.05% | -28.09% | 0.52x | 1.10x | $-12.53 Million |
Industry Comparison
This section compares Sensus Healthcare Inc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $1,818,520,110
- Average return on equity (ROE) among peers: -48.87%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Sensus Healthcare Inc (SRTS) | $48.10 Million | -89.40% | 0.10x | $44.84 Million |
| Abbott Laboratories (ABT) | $17.78 Billion | 20.28% | 1.23x | $153.89 Billion |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $19.91 Million | -270.00% | 1.43x | $15.55 Million |
| Aethlon Medical Inc (AEMD) | $-5.98 Million | 0.00% | 0.00x | $2.51 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $903.35K |
| Adapthealth Corp (AHCO) | $280.85 Million | -57.55% | 5.46x | $1.29 Billion |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $6.89 Million | 30.07% | 0.49x | $6.67 Million |
| Allurion Technologies, Inc. (ALUR) | $-70.49 Million | 0.00% | 0.00x | $7.70 Million |
| Autonomix Medical, Inc. Common Stock (AMIX) | $8.10 Million | -140.88% | 0.21x | $4.44 Million |
| Artivion Inc (AORT) | $17.90 Million | 7.26% | 0.20x | $1.03 Billion |
| Apyx Medical Inc (APYX) | $22.89 Million | 2.69% | 0.23x | $176.29 Million |
About Sensus Healthcare Inc
Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for tr… Read more